News

Regulators demand drug transparency

17-Mar-08

The DoH has promised to act after UK drug regulators called for tougher legislation on disclosure of adverse events by drug manufacturers.

The Medicines and Healthcare products Regulatory Agency (MHRA) wants the European Commission to tighten rules over providing drug safety information.

Companies should be legally obliged to disclose information on adverse effects even if noted outside of the European Union or when used outside of marketing authorisations, the MHRA says.

It also wants clear time scales for reporting information and sanctions for failing to comply.

Health minister Dawn Primarolo promised to strengthen the law 'to make it clear to all pharmaceutical companies that they should disclose any information that would have a bearing on the protection of health'.

The call follows a four-year investigation by the MHRA into handling of information on use of Seroxat (paroxetine) in under-18s by manufacturers GlaxoSmithKline (GSK).

The drug regulators say GSK should have disclosed data from some clinical trials earlier, although government prosecutors saw no realistic prospect of a conviction.

GSK has said it acted 'properly and responsibly'.

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Nursing Professional Issues

Supporting victims of childhood sexual abuse

Health professionals can help patients recover from psychosexual trauma, writes Graham Wilmer. Read More

Rise of the GP-led health centres

As the new 'super-surgeries' open, we consider the possible opportunities for nurses. Joe Lepper rep... Read More

Career Profile - Staff nurse, eating disorders service

Daniel Brown, Roehampton, London Read More

Show all articles

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more

Jobs

 

Job of the Week